{"name":"TrueBinding, Inc.","slug":"truebinding-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPeUx4N1VxLVVxc28zWUFqN2xxa0gwU2xfY2FldkpYcDBDNmFxR2V0azFwVXhGN0dNZFJTd3ZXVzU4cHYtbzZHUmNxVUhKandmdlhuOXM1UHRPbTV6VUs0NEt3WnlSYkZib2JaYTcwM1dOTmlSRzJId0E4bXF1M1FCcmJ6QzFQQ0VtZFVkWGN5aGM0X0FmY1RtQWEzZlNqWWtFQ0pmUHZvNU9SV3Q5LUdiekNaZmo0U2xZNkROM2lMQ05MM1REWkMtLUlYVDg3a29idE4zU3NPekFLRHJUeTZNRzhSSFkzQUhfV0VVbWRTcEtFclpHcUxVYXdXT2JINkhubFBNSzlJSldFMHEyLTliclQwTGpyVlNEWG5XRzdR?oc=5","date":"2025-08-12","type":"trial","source":"GlobeNewswire","summary":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ - GlobeNewswire","headline":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1ObUNxdU9PeGNtS3RIOWxtcnBxZDhlSnhNeUlCbXR0c3VMNG5tbzMyZG1SbWVUQTRiSlppXzctdlpxNG5FRHdKUzFoZWFzNW5xOFJ0cFdDeVI3MzFKbWt4d0xSQnpRN3BSaDA0dTN6Y3ZmU2RYT2kxR1hBTmnSAYIBQVVfeXFMT2w0Zmt3WEpIVk5RQW45LXBtY0NfeUpfNzJGUXhLOWp6T0dLTnBFd1VSSXYtaWFfcDRWMDRCeE10aGFCaGVxQTJSclVpWlUzWjc1dGtlUkxCTjIyYWpwbVdJSGRqSWw5S2E4NEYzMl9ocjZYSS1WY0NHbUlXWFJKaTJadw?oc=5","date":"2025-05-29","type":"pipeline","source":"FOX 26 Houston","summary":"Alzheimer's disease could be reversed with investigational drug - FOX 26 Houston","headline":"Alzheimer's disease could be reversed with investigational drug - FOX 26 Houston","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNdTlUVV9UQ0M2bmowemt4UVFrZHlSbzRpMlZ0dnFfNVdOaTEwb1lPNnNiaHFYZFV5TVBJclBuT2dnZU9OeXhqV2Vtc2NabVpSZXY2bXdNblFvR2t2Sl93MGF0bkgxbzJCblZhWUxuckZXdTlxZExlQ2RiRGtHakNpU3dqNG5uaG4yNkUwYVVDM3hxVW1fbDdGdUdSRGxGanl3aHd1cmE2cWJuaUhOSlBtc242M2VnWnpFRm9EdGJLeGJNWk5EbWRWb19yWW9ob2g5T2dFRjNINlNRYm1fTG41dmxIWU9WQkxhUlJpVGZXcjY3enRJR1liTVIzcXZjZFVSTFVVbWp2alhuOXVLc1oyZ1dQajZlRWptMTVOTHdyRE02YWV1RWNNWXV3c1pxWjVmMXRjM3pubmthc0p5ZEVvMkpkOWZaZlB3TlE?oc=5","date":"2025-04-29","type":"trial","source":"GlobeNewswire","summary":"Phenylketonuria Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Phenylketonuria Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxORndHY3daWUhJWEJGMnZieF93aEs4TW12UXkzV0QxVU1BR2NjZGtmVkhOV0lIZWw2a3o5Z1VMTW9DTnBJZUFIblRGMnJrUThVZk9Sa1Y1UnlIazhCTmx4RlpFTm1GLWNJXzNubGhWbldzQzFYcGN0MmhpZkItMXljYXNoV0RfZEJZeEx1MmxIcmZDd3VibllsOF9CZ0xYLV9ZR0d5U3F3TFRHMURrZmdZTWVzX0Jldkhyam5BVnR2V2h5eUxLbUJOTGxMQUpnb0s0TDBpVEV5Ni12eFQzc3o0R2hyVQ?oc=5","date":"2024-06-06","type":"pipeline","source":"PR Newswire","summary":"Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight - PR Newswire","headline":"Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSWdSOHBwaGwtdE80eUJ4cVJteEg0VHE4M3hCdzNxcG5rQ05ZRU9LeUJGMEw4WU9tMnp0VXFib3lpUmJLenNJTl9kY2h6ZkNLdlVHSUx4WkhLa1BOSEwxcU5qR1FndXhPeFlHVDVLZUVlZWdENUJPWmhJMzhRR1RVcVVEWjhJV1pUZ0VGa29ZUDd6NnJEUU1jcDdYaVdzZ0txWkJjVUxiNUkzZllsek9oTk00dGVSakVKemFDa0xodGh5aDlXQ2xma0l5UUZ4azM1dnlfSDFPVnV2ZnBaQmc?oc=5","date":"2024-06-04","type":"pipeline","source":"PR Newswire","summary":"Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight - PR Newswire","headline":"Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQTk1RjhIcHNLLWhTYVRZVmtIRUY0TjhlWG9lTmE1bERLbXZRTjlZa1k1c2xZY0hTUXV3bVhia19MZGRLM3NhVEFoMkkwUU8wdjNEeHVvRW9Ua25VeGRKQWlUbHJhMEFyeDhVLS1fem13QTRvTElTakFMRHlGWkR0amNsYm9QVFBHeUxR?oc=5","date":"2024-05-10","type":"trial","source":"openPR.com","summary":"Dementia Market 2032: Epidemiology Data, Pipeline - openPR.com","headline":"Dementia Market 2032: Epidemiology Data, Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQN2k4T0wxVnE3UW1mbzI3ZnBTSEw0SmlRalBVNnJZem5iRXhhcGlvRThpcENLVWpxeHd2aFNRWElOS2tiUjJIc0thLWNoNDktSnJ6SEpJTFpHelpaYUcwQWdQUGhvOUZqYTg4RXhDNjBHLTVmZGJ5c25VNTNZMnludG5GeVFxampSSHA3b0E5Y05jVjlhT1piZjdxbDExX1lza2d1LTFZT2dPSS1kR1lSeHNDX3ExZlhqT3pWdGdiR0gySFdUT1RDbWYtb3gwVE9H?oc=5","date":"2023-06-21","type":"pipeline","source":"Clinical Leader","summary":"Advancing Alzheimer's Disease Treatment With An OLE, Expanded Access, & A Better Patient Experience - Clinical Leader","headline":"Advancing Alzheimer's Disease Treatment With An OLE, Expanded Access, & A Better Patient Experience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxNZTEyWU5xQ3NFSHFoZTZyNHhrMHFUeDYwTlhxaDhXLXdWUWltTUJQS0ZwT3lzd3RXaW84amJIbUxQdFVGQWItdTFTck5tSUt6cXUyQUpEZXRkSUl2TU8wX3ZjOGd0b25kZHJucjVSSHhJczNkRUN6Ym9ELUlFX1poUkNrMjF6RVRFRnFmeTA0ZVhUaXVKLTlrUnkzMDhsZFZzcWFmZDNsNmd4clNGNUZaWDJHOUtGVkE3OEpybjhRckRqVjRWRm5aUmFHQzlvWWFsUERaUk1yMUYySEV5Yy1SY2V6bjctNEJoWm4zY1czNHJKNFF3V0t2WHV1TENtenJFY0pNaEplcTVEQlRhZC1NcHlHM3EtMnlZcWRfc2JSZTdPT2FIQUI3RDRMMDhlRWFkNUMyZmRVOEcxNVRaV0tR?oc=5","date":"2023-05-31","type":"trial","source":"PR Newswire","summary":"CTLA-4 Inhibitors Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 40+ Leading Players Wheeling the Therapeutics Segment - PR Newswire","headline":"CTLA-4 Inhibitors Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 40+ Lea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPMTFDQWQ1V3J1a04xa0hHVFBKM3JiS2xBUVIzUWtWSmZoOHZQUlkzSFNjYVVsenVJZUY1c1JvMl9rZzhpM3JwaEFWYnA0ZzV2WWdVeF9LcjhkTUFONHAwU0pEbGl4bzlzZlQzczVleE9OVTBYYU9Bc1E5Sk1FU2stcF9UVkFTZUwtSXJmazBQd2tkTE5oNGkxTF9zamczZHNXSHVUWnVRV3g2Q2Z2WFlucmMwTkQyZGNrUkk1cXVYMlhSc2pQSDFFenlVeThTaVpYRHpvcmd1dmlPdEZZZlF2QmNUeVFwZGotbUJOUFJieFp1a0p2S0dRZmZIYUo0aS1EWnplYV9ZemluVllHZ2tMNlZZSUlUQnRO?oc=5","date":"2023-03-28","type":"regulatory","source":"PR Newswire","summary":"Open-Label Extension Study for Alzheimer's Treatment Showed Disease Reversal in Nearly Half of Study Participants in Just Three Months - PR Newswire","headline":"Open-Label Extension Study for Alzheimer's Treatment Showed Disease Reversal in Nearly Half of Study Participants in Jus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOa29NZmU3S3ZtMnVacE5MN1dweXU2UmVWX1JvSV80SzJqUEpoUjhLNHQ2MlBsdXY5VEExOWRTTUFvVmV4WkV2SGhtSVlXcVFZS1ltTjhTU0p2TE40dko2dlR3UFI1TVU4eTZUeTlJNnZ5T3VneHFVNmdJb0lrLXJlbXFZT2dFVmlIbGVSVV9iUkxHNjdCTkxhTnRkUUtZSEstVVA2QUFiQmM2Zw?oc=5","date":"2022-07-13","type":"pipeline","source":"BioSpace","summary":"Money on the Move: Pfizer Backs Mystery Company, Teva/AbbVie Settle Opioid Suits - BioSpace","headline":"Money on the Move: Pfizer Backs Mystery Company, Teva/AbbVie Settle Opioid Suits","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxONkVCemlISkxsczRNSG8wSjZfTVJBd2hwZHpjb0JOdTZQRFNCYXpma3JVTnlzaW5vLXYxSU5CanBweDUtRldYaUJUWGh6TXJsdnRoYTRSWi1FOXJJZHVsMTVjdVV2dXp2U1VEUWVWZ2lzQnJWd3ExZ2s2cU92VGZxZDdmNlBFb3JGZ3p2SllR?oc=5","date":"2022-07-08","type":"pipeline","source":"Crunchbase News","summary":"TrueBinding Raises $100M For Alzheimer’s Treatment As Sector Grows - Crunchbase News","headline":"TrueBinding Raises $100M For Alzheimer’s Treatment As Sector Grows","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}